As of 2024-12-15, the Intrinsic Value of Redwood Pharma AB (REDW.ST) is
-25.62 SEK. This REDW.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.18 SEK, the upside of Redwood Pharma AB is
-2,261.64%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-25.62 SEK
Intrinsic Value
REDW.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-25.62 - -25.62 |
-25.62 |
-2,261.64% |
| DDM - Stable |
(95.55) - 430.15 |
167.30 |
14018.3% |
| DDM - Multi |
(97.74) - 350.76 |
(276.96) |
-23471.8% |
REDW.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
3.15 |
| Beta |
-1.87 |
| Outstanding shares (mil) |
2.65 |
| Enterprise Value (mil) |
2.33 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.34% |
| Cost of Debt |
5.00% |
| WACC |
4.65% |